Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Biogen Inc. (BIIB) News - StockMarketCap

Stocks›Biogen Inc.☆

● At closeAs of Jul 2, 2026

Biogen Inc.

BIIB✓

HealthcareDrug Manufacturers - GeneralNASDAQ

$216.12+3.04%

$31.91BMarket cap

23.06xP/E ratio

1.11MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$216.12

$6.38 (+3.04%) · 24h

Key metrics

Market cap$31.91B+12.40%

Enterprise value$35.08B

Volume (24h)1.11M

P/E ratio (TTM)23.06x

P/S ratio (TTM)3.24x

Dividend yield0.00%

Shares outstanding147.64M

Trading range

Previous close$209.74

Day range$210.75 - $219.00

52-week range$121.05 - $219.72

Biogen Inc. (BIIB) operates in the Drug Manufacturers - General industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news